Climb Bio
MA - Wellesley HillsBiotechnology
Focus: Climb Bio is an early-stage biotech focused on treatments for neuronal excitability disorders, currently advancing a pipeline of immunology-focused programs from its Wellesley Hills, MA headquarters.
Profile data last refreshed 4h ago · AI intelligence enriched 2w ago
Open Jobs
2+1 this month
Stable — net +1 jobs in 30d
1 added, 0 removed. Backfill posture.
Should You Work at Climb Bio?
AI assessmentA early-stage clinical-stage bet with emerging pipeline catalysts and strong market focus, but hire cautiously given minimal headcount visibility and undisclosed finances.
Why Work Here
- Opportunity to shape clinical development strategy on a focused pipeline with multiple indications (ITP, membranous nephropathy, SLE) for lead candidate Budoprutug.
Data completeness
3/9 — Basic
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Budoprutug
Healthy VolunteersCLYM116
Healthy VolunteersBudoprutug
Systemic Lupus ErythematosusHelp build intelligence for Climb Bio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.